Home

Study doubts MS drug

2000-01-27T00:00:00

Money would be better spent on alternative ways of improving quality of life in people with secondary progressive multiple sclerosis than on the drug beta interferon, according to research conducted in Scotland.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here